Read more

February 25, 2021
1 min read
Save

Proteinuria may predict AKI, ICU admission and mortality in patients with COVID-19

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Measuring proteinuria within 48 hours of hospital admission for COVID-19 may help predict adverse outcomes, as the condition occurred frequently and was strongly associated with AKI, ICU admission and mortality.

“The prognostic value of kidney function impairment during COVID-19 has already been suggested in other series, but our study is the first large series to show that the outcome is associated with simple urine tests, such as [urine protein-creatinine ratio] UPCR and [urine albumin-creatinine ratio] UACR, used in daily practice in contrast with new biomarkers, such as neutrophil gelatinase-associated lipocalin or kidney injury marker-1, that have been evaluated in other situations with high risk of AKI but not yet in early phases of COVID-19,” Alexandre Karras, MD, PhD, of the division of nephrology at Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, and colleagues wrote.

Urine sample
Source: Adobe Stock

To evaluate the prevalence of proteinuria, as well as related outcomes, the researchers conducted a retrospective, single-center observational study of 200 patients hospitalized with COVID-19 who had proteinuria measured within 48 hours of admission.

They found that while most patients had normal kidney function (14% had initial serum creatinine greater than 1.5 mg/dL), 42% had a UCPR that was 1 g/g or above at admission.

“Moreover, our results indicate that this proteinuria contains very small amounts of albuminuria, as the urine albumin-protein ratio is [greater than] 50% for only 8% of patients, even among patients with UPCR [of at least] 1 g/g,” the researchers wrote.

Regarding outcomes for the entire study population, the researchers found UPCR of 1 g/g or greater was associated with higher peak median serum creatinine (1.79 mg/dL vs. 1.06 mg/dL), as well as significant risks for AKI (OR = 3.61), need for dialysis (OR = 4.87), admission to the ICU (OR = 3.55) and mortality during hospitalization (OR = 3.56).

Assessing outcomes for only those with normal kidney function at admission (138 of the total 200) demonstrated similar results. Compared with patients with UPCR of less than 1 g/g, those with UPCR of 1 g/g or greater were at higher risk for ICU admission (77% vs. 44%), subsequent AKI (45% vs. 18%), need for dialysis (22% vs. 4.5%) and mortality (43% vs. 14%).

“This study reveals that COVID-19 is associated with early and frequent tubular proteinuria, which is associated with poor kidney outcome and higher mortality among patients with symptomatic COVID-19,” Karras and colleagues concluded. “The comprehension of the precise mechanisms underlying this tubular injury requires further investigations.”